Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CRO Consolidation: Indian Firm Veeda Buys US CRO

publication date: Jul 17, 2008

The India-based company Veeda Clinical Research continued its acquisitive ways by buying International Oncology Network (ION), a clinical research company with 50 clinical trial sites across the US. ION, headquartered in Texas, was part of Amerisource Bergen. The purchase price was not disclosed. ION will become part of the cancer subsidiary of Veeda, known as Veeda Oncology. Veeda has been active recently in acquisitions. More details...

Stock Symbols: (NYSE: LLY) (NYSE: DNA) (NYSE: SNY) (NYSE: BMY) (NYSE: WX)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital